Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - October 28, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to announce that CEO Iris Bincovich will embark on a 2 day trip on October 29-30 to Munich, Germany with the purpose of meeting investors and potential clients.
Ms. Bincovich will attend an open Q&A session that will take place in the Novotel Mnchen Messe, Willy-Brandt-Platz 1, 81829 Mnchen. Please RVSP at info@innocanpharma.com
Ms. Bincovich will also attend the BEAUTY FORUM MNCHEN by Cosmoprof 2021 where she will meet with prospective clients and distributors at Innocan Stand E73 - Halle B1.
"I am excited to be meeting Innocan's investors and potential clients on my upcoming trip to Germany," said Iris Bincovich, CEO of Innocan Pharma and added, "The German market has a strong appreciation for and understanding of the benefits of CBD, and we are appreciative of their ongoing support and interest of Innocan's innovations."